
WHO strongly recommends antiviral drug for patients with non-severe covid-19
A combination of nirmatrelvir and ritonavir is strongly recommended for patients at highest risk of hospital admission. The World Health Organization ...

A combination of nirmatrelvir and ritonavir is strongly recommended for patients at highest risk of hospital admission. The World Health Organization ...

The World Health Organization (WHO) is issuing an urgent call for accelerated action by leaders and all people to preserve and protect health and miti...

It’s great that you’re taking it—but are you absorbing it? Here’s why vitamin D can get blocked, and how you can help ensure that your body soaks it u...

Findings from a new phase 1 trial led by global health system Cleveland Clinic show that an experimental “gene silencing” therapy reduced blood levels...

Empowering health workers, decision-makers and the public with trusted knowledge about immunization is critical to protecting people from vaccine-prev...

As much as there is for you to love about vitamin D, there’s also still plenty for you to learn…and this supernutrient might even be serving you in wa...

Tuberculosis antigen-based skin tests (TBST), a new class of tests to diagnose TB infection, have been evaluated by the World Health Organization (WHO...

The World Health Organization (WHO) is releasing a strategy to strengthen and scale up genomic surveillance around the world. Historically, few countr...

The International Maternal Pediatric Adolescent AIDS Clinical Trial Network (IMPAACT) P1107 reported the first case of HIV cure in a woman living with...